Health2047 — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Phenomix Sciencesphenomixsciences.cominMay 2024 · $7.8M
Phenomix Sciences applies data analytics and patient data to enable precision obesity medicine, aiming to guide treatment decisions for anti-obesity medications such as GLP-1s and reduce care costs.
AI & Machine LearningBiotechDigital HealthHealthtechMenlo Park, US
Andres Acosta(Director)inMark Bengall(Executive Officer, Director)Mark Bagnall(Executive Officer, Director)inWilliam Ross Higgins(Executive Officer, Promoter)Karl Ronn(Director)Michael Camilleri(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.